PPM1B Antibody

What is PPM1B and what cellular functions does it regulate?

PPM1B is a serine/threonine phosphatase with broad substrate specificity that plays crucial roles in multiple cellular pathways. It dephosphorylates several important kinases including CDK2, CDK6, PRKAA1, and PRKAA2 in vitro. PPM1B acts as a negative regulator of antiviral signaling by dephosphorylating TBK1 at Ser-172, which is essential for TBK1-mediated antiviral responses. Additionally, PPM1B plays an important role in terminating TNF-alpha-mediated NF-kappa-B activation through dephosphorylating and inactivating IKBKB/IKKB . The enzyme's diverse functions make it a significant target for immunological and cell signaling research.

What applications are PPM1B antibodies typically used for?

PPM1B antibodies are primarily employed in several key research applications including:

• Western Blotting (WB): For detecting PPM1B protein expression levels in cell and tissue lysates

• Immunoprecipitation (IP): For isolating PPM1B protein complexes to study protein-protein interactions

• Immunohistochemistry (IHC): For visualizing PPM1B expression patterns in tissue sections

Different antibodies show variability in their optimal applications. For example, Abcam's ab70804 is recommended for IP and WB applications with human samples , while Proteintech's 67647-1-Ig has been validated for WB, IHC, and ELISA applications with human, mouse, and rat samples .

What molecular weights should researchers expect when detecting PPM1B?

PPM1B exists in multiple isoforms with different molecular weights. According to the available data:

• The calculated molecular weight of the full-length protein is approximately 53 kDa (479 amino acids)

• Observed molecular weights in experimental systems include bands at 36 kDa and 53 kDa

• Proteintech's antibody (67647-1-Ig) can identify four different isoforms with molecular weights ranging from 36-55 kDa

Researchers should anticipate potential variation in band patterns depending on the cell type, tissue source, and experimental conditions used.

What species reactivity should be considered when selecting a PPM1B antibody?

When selecting a PPM1B antibody, species reactivity is a critical consideration. Available antibodies demonstrate different cross-reactivity profiles:

• Abcam's ab70804 has been validated for human samples but may cross-react with other species based on sequence homology

• Proteintech's 67647-1-Ig has been tested and confirmed to react with human, mouse, and rat samples

Researchers should verify the species reactivity information provided by manufacturers and consider preliminary validation experiments if working with untested species or unusual experimental systems.

How can researchers validate PPM1B antibody specificity for their experimental system?

Validating antibody specificity is crucial for generating reliable data. For PPM1B antibodies, researchers should consider:

• Positive and negative control samples: Use cell lines with known PPM1B expression levels (e.g., HeLa, HEK-293, Jurkat cells) as positive controls . Consider PPM1B knockdown (shRNA) or knockout samples as negative controls.

• Multiple antibody approach: Utilize antibodies from different vendors or those recognizing different epitopes of PPM1B.

• Molecular weight verification: Confirm that detected bands match expected molecular weights (36-55 kDa range) for PPM1B isoforms .

• RNA interference validation: Compare antibody signals between control cells and cells with suppressed PPM1B expression using shRNA. The paper by Zhao et al. describes effective PPM1B shRNA sequences: 5′-AATGCAGGAAAGCCATACTGA-3′ (sh-PPM1B-1) and 5′-AACTTCTGGAGGAGATGCTGA-3′ (sh-PPM1B-2) .

• Phosphatase-deficient mutant: Consider using the phosphatase-deficient R179G mutant of PPM1B as a functional control in activity assays .

What experimental approaches are recommended for studying PPM1B's role in antiviral signaling?

When investigating PPM1B's role in antiviral signaling pathways, researchers should consider:

• Reporter assays: Utilize IFNβ luciferase reporter assays to assess the effect of PPM1B overexpression or knockdown on TBK1-induced IFNβ expression, as demonstrated by Zhao et al.

• Phosphorylation analysis: Monitor TBK1 phosphorylation at Ser172 and IRF3 phosphorylation at Ser396 using phospho-specific antibodies to examine PPM1B's effect on these key signaling mediators .

• Co-immunoprecipitation studies: Investigate the physical interaction between PPM1B and TBK1 or other components of antiviral signaling pathways using IP with PPM1B antibodies .

• Viral challenge experiments: Assess the functional impact of PPM1B manipulation on viral replication (e.g., VSV) and IFNβ production in cell culture systems .

• Comparison of wild-type vs. phosphatase-deficient mutant: Include the phosphatase-deficient R179G mutant of PPM1B as a control to determine whether observed effects depend on PPM1B's phosphatase activity .

What are the optimal conditions for in vitro studies of PPM1B phosphatase activity?

For studying PPM1B phosphatase activity in vitro, researchers should consider the following conditions:

• Buffer composition: Use a phosphatase buffer containing 250 mM imidazole (pH 7.2), 1 mM EGTA, 25 mM MgCl₂, 0.1% 2-mercaptoethanol, and 0.1% BSA .

• Recombinant protein preparation: Express and purify His-tagged PPM1B wild-type and phosphatase-deficient R179G mutant proteins for use in activity assays .

• Substrate preparation: Immunoprecipitate phosphorylated substrates (e.g., FLAG-TBK1) from cell extracts using appropriate antibodies and affinity beads .

• Reaction conditions: Conduct phosphatase reactions at 30°C for 30 minutes, followed by termination by boiling in protein sample buffer .

• Analysis method: Assess dephosphorylation by immunoblotting with phospho-specific antibodies targeting the relevant phosphorylation sites (e.g., phospho-TBK1 Ser172) .

How should experiments be designed to investigate PPM1B interactions with upstream antiviral signaling components?

When studying PPM1B's interactions with upstream components of antiviral signaling pathways:

• Overexpression studies: Examine the effect of PPM1B overexpression on RIG-I-CARD, MAVS, and TBK1-mediated IFNβ luciferase reporter activities and IRF3 phosphorylation, as demonstrated by Zhao et al.

• Structure-function analysis: Compare wild-type PPM1B with its phosphatase-deficient R179G mutant to determine whether catalytic activity is required for observed effects on antiviral signaling .

• Sequential analysis: Study the temporal dynamics of PPM1B association with TBK1 during viral infection to understand the regulation of this interaction .

• Cytokine production measurement: Measure IFNβ production by ELISA or qPCR using primers such as 5′-CACACAGACAGCCACTCACC-3′ and 5′-TTTTCTGCCAGTGCCTCTTT-3′ .

• Genetic manipulation: Use PPM1B knockdown cells (created via shRNA or CRISPR) to examine how reduced PPM1B levels affect virus-induced IRF3 phosphorylation and IFNβ production .

What are the recommended protocols for Western blot detection of PPM1B?

For optimal Western blot detection of PPM1B:

• Sample preparation: Use whole cell lysates from appropriate cell lines (e.g., HeLa, HEK-293T, Jurkat, A549) .

• Loading amount: Load approximately 50 μg of protein lysate per lane for reliable detection .

• Antibody concentration: Use anti-PPM1B antibodies at optimized dilutions:

  • Abcam ab70804: 0.04 μg/mL

  • Proteintech 67647-1-Ig: 1:5000-1:50000 dilution

• Expected results: Anticipate bands at approximately 36 kDa and 53 kDa, with potential variation depending on the cell types and antibody used .

• Controls: Include lysates from cells with known PPM1B expression (e.g., Jurkat, HEK-293T, A549) as positive controls .

What are the optimal conditions for immunohistochemical detection of PPM1B?

For successful immunohistochemical detection of PPM1B in tissue sections:

• Antibody selection: Choose antibodies validated for IHC applications, such as Proteintech's 67647-1-Ig .

• Antibody dilution: Use a dilution range of 1:500-1:2000 for optimal staining .

• Antigen retrieval: Perform antigen retrieval with TE buffer (pH 9.0) or alternatively with citrate buffer (pH 6.0) .

• Positive control tissues: Include human breast cancer tissue or mouse skeletal muscle tissue as positive controls, where PPM1B staining has been validated .

• Detection system: Use an appropriate secondary antibody and detection system compatible with the primary antibody host species and isotype (Mouse IgG1 for Proteintech's antibody) .

How can researchers troubleshoot common issues in PPM1B detection?

When encountering problems with PPM1B detection, consider:

• Multiple bands: PPM1B exists in multiple isoforms (36-55 kDa). If unexpected bands appear, verify their identity through:

  • Comparison with PPM1B knockdown samples

  • Literature review of known isoforms

  • Blocking peptide competition assays

• Weak or no signal:

  • Increase antibody concentration

  • Extend incubation time

  • Optimize antigen retrieval (for IHC)

  • Ensure fresh samples with minimal degradation

  • Verify that your experimental system expresses detectable levels of PPM1B

• High background:

  • Increase blocking time/concentration

  • Reduce primary antibody concentration

  • Increase washing steps duration/frequency

  • Use fresher antibody solutions

• Variable results between experiments:

  • Standardize lysate preparation methods

  • Maintain consistent freeze-thaw cycles

  • Use internal loading controls

  • Prepare larger batches of antibody dilutions

What controls should be included in PPM1B antibody-based experiments?

Proper experimental controls for PPM1B studies include:

• Positive controls:

  • Cell lines with confirmed PPM1B expression (HeLa, HEK-293, Jurkat, A549, HepG2, K-562, HSC-T6, NIH/3T3)

  • Recombinant PPM1B protein

  • Tissues with known PPM1B expression (human breast cancer tissue, mouse skeletal muscle)

• Negative controls:

  • PPM1B knockdown or knockout samples

  • Isotype control antibody (Mouse IgG1 for Proteintech's antibody)

  • Secondary antibody-only controls

• Functional controls:

  • Wild-type PPM1B vs. phosphatase-deficient R179G mutant for activity assays

  • Comparison of responses to viral infection in PPM1B-manipulated vs. control cells

• Technical controls:

  • Loading controls for Western blot (β-actin, GAPDH)

  • Housekeeping gene controls for qPCR (β-actin)

  • Cell viability assessment when manipulating PPM1B expression

What are the optimal storage conditions for PPM1B antibodies?

To maintain antibody performance over time:

• Storage temperature: Store PPM1B antibodies at -20°C for long-term storage .

• Buffer composition: PPM1B antibodies are typically provided in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 for stability .

• Aliquoting considerations: For the -20°C storage condition, aliquoting is generally unnecessary, but may be beneficial for frequently used antibodies to avoid repeated freeze-thaw cycles .

• Shelf life: When stored properly, PPM1B antibodies should remain stable for one year after shipment .

• Working solution handling: Once diluted for experiments, antibody solutions should be prepared fresh or stored at 4°C for short periods (typically less than one week).

How should researchers select between different PPM1B antibody options?

When choosing between available PPM1B antibodies, consider:

• Application compatibility: Select antibodies validated for your specific application (WB, IP, IHC) .

• Species reactivity: Ensure the antibody recognizes PPM1B from your species of interest (human, mouse, rat) .

• Epitope location: Consider antibodies targeting different regions of PPM1B for confirmation or specific isoform detection:

  • Abcam's ab70804 targets the C-terminal region (aa 450 to C-terminus)

  • Verify the epitope location of other antibodies with the manufacturer

• Validation data: Review the manufacturer's validation data, including Western blot images and IHC staining patterns .

• Literature citations: Consider antibodies used successfully in published research, such as those cited in functional studies of PPM1B's role in antiviral signaling .